A61K36/254

Red ginseng saponin extract and method for preparing the same
09744201 · 2017-08-29 ·

Disclosed is a method for preparing a red ginseng saponin extract. In the method, saponin components and non-saponin components are extracted from red ginseng and the non-saponin components are selectively removed from the red ginseng extract to prepare a red ginseng extract containing large amounts of the saponin components. According to the method, saponin components are extracted from red ginseng in high yield and non-saponin components are efficiently removed from the extract. Also disclosed is a red ginseng saponin extract prepared by the method. The red ginseng saponin extract is free of precipitable substances and putrefactive substances, such as starch and free sugars, and contains high-purity saponin components at high concentrations. The red ginseng saponin extract is prevented from being discolored and precipitated even after long-term storage, achieving good storage stability and high marketability.

COMPOSITIONS FOR THE TREATMENT OF AGE RELATED DISORDERS
20170258862 · 2017-09-14 ·

The invention is directed to compositions for the prophylaxis, treatment and recovery of age related disorders. Compositions comprising a combination of parts of plants or plant extracts belonging to Crassulaceae, Araliaceae and Schisandraceae for the prophylaxis and treatment of age related disorders.

COMPOSITIONS FOR THE TREATMENT OF AGE RELATED DISORDERS
20170258862 · 2017-09-14 ·

The invention is directed to compositions for the prophylaxis, treatment and recovery of age related disorders. Compositions comprising a combination of parts of plants or plant extracts belonging to Crassulaceae, Araliaceae and Schisandraceae for the prophylaxis and treatment of age related disorders.

COMPOSITIONS FOR THE TREATMENT OF AGE RELATED DISORDERS
20170258862 · 2017-09-14 ·

The invention is directed to compositions for the prophylaxis, treatment and recovery of age related disorders. Compositions comprising a combination of parts of plants or plant extracts belonging to Crassulaceae, Araliaceae and Schisandraceae for the prophylaxis and treatment of age related disorders.

COMPOSITIONS FOR THE TREATMENT OF OVERTRAINING SYNDROME
20170252389 · 2017-09-07 ·

The invention is directed to compositions for the prophylaxis, treatment and recovery of overtraining syndrome. Compositions comprising a combination of parts of plants or plant extracts belonging to Crassulaceae, Araliaceae and Schisandraceae for the prophylaxis and treatment of overtraining syndrome. In a preferred embodiment the composition further comprises parts of plants or plant extracts of Asteraceae and or pantothenic acid or salts thereof.

COMPOSITIONS FOR THE TREATMENT OF OVERTRAINING SYNDROME
20170252389 · 2017-09-07 ·

The invention is directed to compositions for the prophylaxis, treatment and recovery of overtraining syndrome. Compositions comprising a combination of parts of plants or plant extracts belonging to Crassulaceae, Araliaceae and Schisandraceae for the prophylaxis and treatment of overtraining syndrome. In a preferred embodiment the composition further comprises parts of plants or plant extracts of Asteraceae and or pantothenic acid or salts thereof.

COMPOSITIONS FOR THE TREATMENT OF OVERTRAINING SYNDROME
20170252389 · 2017-09-07 ·

The invention is directed to compositions for the prophylaxis, treatment and recovery of overtraining syndrome. Compositions comprising a combination of parts of plants or plant extracts belonging to Crassulaceae, Araliaceae and Schisandraceae for the prophylaxis and treatment of overtraining syndrome. In a preferred embodiment the composition further comprises parts of plants or plant extracts of Asteraceae and or pantothenic acid or salts thereof.

Anti-resorptive and bone building dietary supplements and methods of use

Disclosed herein are dietary supplement compositions and methods for increasing or stimulating bone growth, decreasing or preventing bone resorption, increasing bone strength, improving bone structure, and improving bone architecture comprising a first composition comprising a combination of at least two of: quercetin, Rehmannia sp., Rehmannia sp. root, Siberian ginseng, Sophora japonica, licorice, and ipriflavone, wherein the combination of the first composition increases bone morphogenic protein-2 gene, promoter or protein expression; and a second composition comprising an extract of pomegranate in combination with at least one of Siberian ginseng, Ginkgo biloba, green tea, Sophora japonica, Rehmannia sp., grape seed, Dong Quai, and ipriflavone, wherein the combination of the second composition inhibits the expression of RANK-L.

Anti-resorptive and bone building dietary supplements and methods of use

Disclosed herein are dietary supplement compositions and methods for increasing or stimulating bone growth, decreasing or preventing bone resorption, increasing bone strength, improving bone structure, and improving bone architecture comprising a first composition comprising a combination of at least two of: quercetin, Rehmannia sp., Rehmannia sp. root, Siberian ginseng, Sophora japonica, licorice, and ipriflavone, wherein the combination of the first composition increases bone morphogenic protein-2 gene, promoter or protein expression; and a second composition comprising an extract of pomegranate in combination with at least one of Siberian ginseng, Ginkgo biloba, green tea, Sophora japonica, Rehmannia sp., grape seed, Dong Quai, and ipriflavone, wherein the combination of the second composition inhibits the expression of RANK-L.

Composition for preventing, treating or improving prostate disease containing acanthopanax sessiliflorus, phragmites rhizome, and pinus densiflora extracts as active ingredient

The present invention relates to a composition for preventing, treating or improving a prostate disease containing Acanthopanax sessiliflorus, Phragmites rhizome, and Pinus densiflora extracts as an active ingredient. According to the present invention, the complex extract of Acanthopanax sessiliflorus, Phragmites rhizome, and Pinus densiflora has an effect of inhibiting the activity of 5α-reductase associated with benign prostatic hyperplasia and has an advantage of having a few or no side effects of reducing a male sexual function by using a synthetic compound in the related art using ingredients derived from natural plants. Further, it is confirmed that in a complex extract obtained by mixing Acanthopanax sessiliflorus, Phragmites rhizome, and Pinus densiflora extracts at a more proper ratio, the 5α-reductase inhibitory activity is significantly excellent.